AI Medical Solutions promotes intelligent attention to visual health, detecting in time and helping to treat eye conditions that cause blindness that is avoidable if treated in a timely manner, with safe, efficient and affordable examinations.
Our purpose is to provide inclusive healthcare, in order to transform patient care services.
Ai
Medical
Solutions
WHAT DO WE DO?
Today, visual dysfunctions are very common problems that affect approximately 40% of children under 15 years of age in Europe, while three out of four adults face some visual health problem.
Obtaining an early and accurate diagnosis is essential to effectively treat any developing pathology and thus avoid long-term problems. However, currently, as in many areas of medicine, there is a lack of specialized vision professionals to address patients in a timely manner.
What is our solution? We propose to integrate into this process all the advantages of digital technologies and Artificial Intelligence, the development of which allows us to advance in the diagnosis and prevent in the best way the appearance of all those pathologies that cause blindness.
It is essential to keep in mind that The International Agency for the Prevention of Blindness IAPB projects a 55% increase in vision loss in the world's population in the next 30 years, which translates into 600 million people affected.
suffer from a visual impairment that could have been avoided or has not yet been treated.
millions of
people
At least 1,000
The 90%
of the loss
Of vision
It can be prevented with early detection and treatment.
DATA
GLOBAL
At the current rate, vision loss will increase to
1,700
millions of
people in 2025
It is estimated that current eye health systems will not be able to cope with future needs.
MODEL
BUSINESS
“ARTIFICIAL INTELLIGENCE PROVIDES A COST-EFFECTIVE SOLUTION TO ADDRESS THE LACK OF SPECIALISTS AND EXPAND EYE CARE SERVICES”
OPTICS
We want to invite you to be part of a new model of cutting-edge visual care, close and accessible, with the aim of helping to timely treat the eye conditions that cause avoidable blindness and collaborate in the control of the development of these pathologies by recommending to patients to go to their doctor as soon as any sign of any disease is detected.
We have OpthAI, an AI solution and screening software that helps eye care professionals safely and efficiently perform pathology screening tests for Diabetic Retinopathy, AMD, Glaucoma, Macular Edema and Drüsen.
* In August we will incorporate degenerative myopia and cataract.
The automated algorithm (AI) module detects signs of ocular diseases by analyzing images of the fundus of the eye, you only need to have a retinograph to obtain a report in less than 5 seconds.
EYE CLINICS AND PRIVATE HEALTH CENTERS
We are committed to promoting valuable medicine focused on patient care, providing additional tools to Health Centers. Collaboration in the implementation of more advanced technologies allows us to approach the current patient management model differently. For this we propose a new model of clinical support and assistance.
Through new and innovative technologies, we seek to maximize results, improve efficiency and coverage in the face of greater patient demand, positively impacting their lives and within the health ecosystem. Ophthalmological Clinics and Private Health Centers are essential to improve healthcare activity in the field of medical and surgical retina.
Mikajaki can respond to this demand, as it has redefined ophthalmological diagnosis through virtual agents, robotics and artificial intelligence technologies in a simplified solution: the Ariane Ophthalmology Suite. It is the first automatic diagnostic platform complete with a SmartVision Comprehensive Ophthalmic Diagnostic Report with prescriptions and surgical planning in just 6 minutes.
PUBLIC HEALTHCARE
We are committed to promoting valuable medicine focused on patient care, with the goal of providing more tools within the health ecosystem. This will allow us to more effectively address avoidable vision loss and improve screening in the population, accelerating early detection processes, especially in the case of diseases that usually develop silently.
The aging population, coupled with the current diabetes pandemic, has led to tens of millions of people requiring diagnosis and treatment for eye health problems. The lack of vision professionals and timely eye diagnostic processes puts millions of people at risk of developing diseases that could threaten their vision.
OphtAI can provide access and availability to screening for the main pathologies that can cause blindness, using a certified, reliable and completely accessible algorithm. Which subsequently directs specialists to collaborate in timely treatment.
OUR
PARTNERS
“NUESTROS VALIOSOS PARTNERS SON FUNDAMENTALES PARA NUESTRO ÉXITO. JUNTOS COLABORAMOS PARA TRANSFORMAR LA ATENCIÓN MÉDICA, LLEVANDO SOLUCIONES INNOVADORAS A PACIENTES EN TODO EL MUNDO, RESPALDADOS POR UN SÓLIDO EQUIPO DE APOYO EN EL SERVICIO DE POSTVENTA”.
IT IS AN ARTIFICIAL INTELLIGENCE SOLUTION DEVELOPED FOR THE DETECTION OF THE MAIN EYE PATHOLOGIES:
Diabetic retinopathy
Diabetic Macular Edema
Glaucoma
Macular Degeneration
Age-related (AMD)
Drusen
The promise of OphtAI is to provide preventive care, since it allows early detection of the main retinal pathologies in a few seconds, facilitating a timely referral to specialized services, thus avoiding the development of the aforementioned pathologies.
ARTIFICIAL INTELLIGENCE - ROBOTICS - VIRTUAL AGENT
The first Complete Automatic Diagnostic platform: SmartVisionâ„¢ Comprehensive Ophthalmic Diagnostic Report with prescriptions and surgical planning in just 6 minutes .
MIKAJAKI (Geneva) has redefined ophthalmological diagnosis with virtual agents, robotics and artificial intelligence (AI) technologies in a simplified solution: the Ariane Ophthalmology Suite.
MIKAJAKI combines cutting-edge technologies with a comprehensive diagnostic approach to provide efficient, reliable and accessible eye care services to a broader population.
The EyeLibâ„¢ is a self-contained, compact (with a footprint of less than 2 square meters), fully automatic and robotic optoelectronic diagnostic station. The EyeLibâ„¢ uses an integrated suite of 10 technologies (including anterior and posterior OCT, including HD corneal epithelial map and ocular biometry, RGCL, RNFL, retinography, wavefront refraction and aberrometry, anterior and posterior elevation topography , Scheimpflug analysis, backillumination; tonometry) to capture and measure more than 100 anatomical or optical parameters of the patient's eyes, in less than 6 minutes. The station can be used as a point-of-care supervised exam or as part of a telemedicine process.
